
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
Greek researchers conducted a study in 69 children with febrile illness who were admitted to a hospital with a diagnosis of a bacterial or viral infection to assess established iron indices in acute febrile infections and to explore whether serum iron distribution differs depending on whether the infection is bacterial or viral.






